chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Alligator like skin; Right arm was swollen; R arm was reddened; R amr covid arm; Sore arm on the day after the vaccine; Large big red welt on arm after receiving her first dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SKIN EXFOLIATION (Alligator like skin), VACCINATION SITE REACTION (R amr covid arm), VACCINATION SITE URTICARIA (Large big red welt on arm after receiving her first dose of the Moderna COVID-19 vaccine), VACCINATION SITE PAIN (Sore arm on the day after the vaccine) and VACCINATION SITE SWELLING (Right arm was swollen) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Graves' disease since September 2016. Concomitant products included METHIMAZOLE, ATENOLOL, VITAMIN D NOS and VITAMIN B12 NOS for Graves' disease.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE URTICARIA (Large big red welt on arm after receiving her first dose of the Moderna COVID-19 vaccine). On 11-Mar-2021, the patient experienced VACCINATION SITE PAIN (Sore arm on the day after the vaccine). On 19-Mar-2021, the patient experienced VACCINATION SITE REACTION (R amr covid arm). On an unknown date, the patient experienced SKIN EXFOLIATION (Alligator like skin). an unknown date, the patient experienced VACCINATION SITE SWELLING (Right arm was swollen) and VACCINATION SITE ERYTHEMA (R arm was reddened). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at an unspecified dose and frequency. On 28-Mar-2021, VACCINATION SITE REACTION (R amr covid arm) had resolved. At the time of the report, SKIN EXFOLIATION (Alligator like skin), VACCINATION SITE URTICARIA (Large big red welt on arm after receiving her first dose of the Moderna COVID-19 vaccine), VACCINATION SITE SWELLING (Right arm was swollen) and VACCINATION SITE ERYTHEMA (R arm was reddened) outcome was unknown and VACCINATION SITE PAIN (Sore arm on the day after the vaccine) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Follow-up received on 08-May-2021 contains updated information of patient initials, pregnancy information, second dose details of suspect product, action taken with suspect product and additional non-serious events.
Initial and follow-up information has been received from a physical therapist concerning a 5 year old female, who on 26-OCT-2007 was vaccinated with a first dose of PEDVAXHIB.  Subsequently, since the vaccination the patient has experienced strep throat.  It was reported that the patient had failed two courses of antibiotics.  At the time of the report, the patient had not recovered.  No product quality complaint was involved.  Follow-up information indicated that it was later determined that the strep throat was unrelated to the vaccination.  Additional information is not expected.
A spontaneous report was received from 17Dec2014 from the father of twins (age not provided) (see MARRS case # 1412USA011108 for second case) regarding a dose of LIQUID PEDVAXHIB. The father reported "my twins were scheduled to receive their second dose of PEDVAX today but they were given both the second and third dose during the same visit and not with 2 months in between like the product literature says." No adverse effects were reported. The father made no mention of the first dose of LIQUID PEDVAXHIB. The father reported he spoke with the physician. The father did not wish to provide specific information. No further information was provided. Additional information is expected.
Rash on her right side. Hot to touch. Spread around her arm to the elbow. Her hand was swollen. She was treated for cellulitis.
I noticed a lump above my left clavical.  Not sure if it is a swollen lymphnode.  It is painful to palpation and still present.
vomiting; severe headache; fatigue; body aches; This is a spontaneous report from a contactable nurse (patient). A 47-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 intramuscular, administered in right arm on 11Feb2021 19:00 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included COVID-19. The patient was not pregnant at the time of vaccination. Concomitant medications were not reported. The patient previously took the bnt162b2, dose 1 intramuscular, administered in right arm on 19Jan2021 06:30 for COVID-19 immunisation, trimethoprim / sulfamethoxazole (BACTRIM) and experienced allergy to trimethoprim / sulfamethoxazole. On 14Feb2021 07:30, the patient experienced vomiting, severe headache, fatigue, and body aches. It was unknown if the patient had treatment for the events. The patient had not been tested for COVID-19 since the vaccination. Outcome of the events was unknown.  The following information on the batch number has been requested.
COVID-19 infection (confirmed); COVID-19 infection (confirmed); This is a spontaneous report received from a contactable reporter (healthcare professional). A 63-year-old female patient received BNT162b2 (BNT162B2), on 25Jan2021 as dose 1, single and on 15Feb2021 as dose 2, single for covid-19 immunisation. The patient's relevant medical history included: "Psoriatic Arthritis-Spondyloarthritis", start date: 2013 (ongoing); "Sinusitis", start date: 2011 (unspecified if ongoing); "Thyroid Problem" (unspecified if ongoing); "Back or Spine problem" (unspecified if ongoing); "Depression" (unspecified if ongoing); "Upper respiratory infection", start date: 2015 (unspecified if ongoing); "Gastroenteritis", start date: 2017 (unspecified if ongoing); "Hemorrhage (non-serious bleed)", start date: 2017 (unspecified if ongoing); "Conjunctivitis", start date: 2018 (unspecified if ongoing); "Atypical chest pain", start date: 2018 (unspecified if ongoing); "Non-Smoker" (unspecified if ongoing). Concomitant medications included: AZULFIDINE oral, start date: 23Jan2020, stop date: 01Nov2022; NSAIDs, oral (ongoing). The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID-19 infection (confirmed)".   No follow-up attempts are possible. No further information is expected.; Sender's Comments: The contributory role of BNT162b2 to the reported drug ineffective event cannot be excluded since a lack of effect can generally be expected for any medicinal product as a 100% success rate cannot be reasonably assumed in every patient treated.
inadvertent use of expired vaccine; notified mom; supervisor notified MD; MFR notified; did not do lab work; did not repeat shot suggested that use of DTP vax was not contraindicated recommended parent reconsider it's use
RN1 alerted Lead RN at 15:00 that a mother and her minor daughter came to the clinic so the daughter could receive her 2nd dose of the Moderna vaccine.  Lead RN spoke to the minors mother, and reviewed both vaccination cards to confirm the client had been vaccinated inappropriately on 03/27/21.  The minor is 17 years old and was vaccinated with her 1st Moderna shot at another clinic.  The mother indicated that when she took her daughter back to the clinic on 04/24/21 to receive her 2nd shot, they declined her because she is under age 18, even though they had administered her 1st shot.  The client received Moderna dose #1 COVID vaccine, Lot# 020B21A.  Lead RN confirmed it was appropriate for the minor client to receive the 2nd dose of Moderna to complete the series, per CDC Guidelines. Lead RN & RN1 educated the client and her mother regarding Moderna's suggested application to 18 years and older only.  Lead RN then confirmed with the client and the mother that the client had not experienced any type of adverse reaction to the first dose.  The minor client and their mother also denied any significant medical history, current medications, supplements, or allergies. The minor client and her mother verbalized understanding and expressed a desire to proceed with the second vaccination.  Lead RN & RN1 reinforced to the client and her mother to please stay for the full 15 minutes in the observation area, and explained that both a VAERS and VERP report would both be submitted to document the incident of the minor client receiving Moderna as an unauthorized age group. The client received Moderna vaccination #2 lot# 021C21A from RN1 at 15:09.  Lead RN checked on minor client in the observation room at 15:35 where both the client and her mother denied any side effects and left the observation room.  Client was ambulating independently with a steady, even gait, with her mother.
Shortly after the second vaccination I started developing frequent occular migraines. I had them occasionally before, but they became very frequent. I also had very bad pain in my wrists, which is one of my indications of inflammation. I had none of the regular advertse symptoms, like chills, fever, etc, so didn't associate with the vaccine. Less than one month after the second shot I experienced intense occular migraine (no pain), dizziness and nausea. Went to ER the next morning, and I had had a stroke. The neurologist says can't tell if due to migraine, but there is a rare type of stroke caused by occulat migraine.
This patient presented tot he office 48 hours after administration with a 7 cm edematous area on his right deltoid, the site was warm to touch. Temp Wnl 98.9. Complains of pain at the site. The patient is to return to the office in two weeks for a follow up.
Large (egg size lump at the injection site with itching to hat has lasted until 3//8/2021
I dont know type of flu shot. No treatment given. Event-woke up in severe pain & couldn't move legs for about an hour then got to walker. Legs still painful and hard to walk.
Chills began within 2 hours of injection.  Fever rose to 101 within 6 hours and lasted for approximately 48 hours.  Chills lasted the entire time the fever lasted.  After the fever came down to below 100, bodyache became more recognizable.  Most unusual pain, which began while the temperature was above 100, was in the muscles connecting my neck to the shoulders, more severely on the left-side where the injection was administered.  The pain was so severe that it felt the muscle was tense, numb and itchy at the same time. The severity of the pain made it feel like the throat was closing up even though I knew it was not true because I did not have trouble breathing.  This pain lasted (in similar intensity) approximately about 36 hours. After this, on the third day, most of the pain was gone but I experienced dizziness, nausea, and diarrhea.  I had a loss of appetite the whole time (over 72 hours) I was experiencing these side effect symptoms.
On 8/7/13 - left deltoid, redness 3 1/2 cm by 4 cm, hard lump, swelling, no fever today. Felt warm. Treatment was iced pack to put on arm when needed.
I had significant arm pain starting the day of the vaccine and lasting 2 days. Since then I have had no other symptoms until today, when I noticed a blotchy red ring around the vaccine site. It is slightly raised, but neither hurts nor itches.
Nausea, temperature recorded at 94.5F, chills, dizziness,  vomiting, chest pain,  fatigue
Eight days after first shot the right elbow has developed a warm, itchy rash.  Topical hydrocortisone and Benadryl cream helps with the symptoms.  There has been a red bump about 1 inch diameter as the center of the reaction, with lighter itching radiating about an inch or two from that location.
chills; This case was reported by a consumer via interactive digital media and described the occurrence of chills in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, 1 day after receiving Shingles vaccine, the patient experienced chills. On an unknown date, the outcome of the chills was recovered/resolved.   It was unknown if the reporter considered the chills to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received dose of Shingles vaccine and felt severe chills. The event severe chills was lasted for four hours. The follow-up would not possible as no contact details were available. For 2nd dose refer case US2021AMR204606, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR204606:same patient
Monday afternoon pt received the Menactra vaccine.  When he awoke the next morning, Tuesday, around 9:30AM he had a stomach ache.  When he got up he immediately vomited.  He felt better and laid back down.  He had the chills and within the hour was vomiting again.  I called his Doctor and informed her of this and asked for Ondansetron tablets and mentioned hydration.  By this time it was 3:00PM and pt had not urinated since the previous day.  He had his graduation ceremony that night at 7PM and he tried and tried to get up and get ready for that.  By now, around 6:30PM he had a fever, was continuing to vomit, and still had not urinated.  He was becoming increasingly lethargic and it was clear there was no way he would make it to his graduation.  I am a Pediatric Anesthesiologist and was growing inceasingly concerned about hydration and that this was a reaction to the vaccine.  By 7:30PM pt was having difficulty ambulating and his speech was very slow and he would barely open his eyes.  At this point I took him to a nearby Station House where an EMT placed an IV.  After 3 liters of NS, pt finally perked up a little bit.  We hep locked the IV and I took supplies home with me.  At 10PM he finally urinated.  Throughout the night I gave him 2 more liters of fluid and he again urinated at 6AM Wednesday moring.  By then, he said he felt much better.  He ate a piece of toast and a few bites of egg.  He then went back to sleep for the next 6 hours.  After the IV was started the Tuesday night, he had no further emesis.  There was no one else sick in the home nor has there been since nor was he around anyone with gastroenteris prior to this.  Had I taken him to an emergency room, and I would have by ambulance had he not responded to the IV fluid, he would have been hospitalized overnight and probably discharged the following afternoon and there would have been laboratory data. I think it was his Right arm, but that, the lot number, and the nurse's name administering and be gotten from the Doctor's office.
Admitted on November 16th with fatigue and sleepiness for 3 days.  Patient currently getting chemotherapy q. 3 weeks. He underwent a CT abdomen and pelvis on November 8th which showed worsening of his hepatic lesions with extension of tumor thrombus into hepatic vein.  Patient was found to be COVID positive.  PE with evidence of pulmonary infarct again seen.  Abdominal aortic aneurysm up to 4.8 cm which is similar to prior.  1/2 blood cultures positive for Klebsiella species.  Infectious Disease consulted and placed on zosyn.  I have discussed case with Dr.  Recommended GI consult.  I have consulted Dr. Patient underwent ERCP on November 17th which showed biliary obstruction and prior stents were removed, stone or debris  was extracted and 2 new biliary stents were placed. Antibiotic switched to IV Rocephin.  Repeat blood cultures drawn on November 21st with no growth so far.    PT will be on Levaquin 500 mg daily for another week per ID recommendations. Stable for discharge He is out of his infectious period of COVID. Discharged on 11/25/21
for 3 days immed following inject cont fever 104.6 lowest; 105 highest; excessive high pitched crying/nearly non-stop; excessive sleepiness but only periodicly able to sleep; explosive bloody diarrhea; 2 convuls observed; failure to breath;
This spontaneous report as received from a medical assistant regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 21-OCT-2015 the patient was vaccinated with improperly stored RECOMBIVAX HB (lot # L004754, expiry date- 10-NOV-2016) (dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from same reporter. Additional information has been requested.
Information has been received from a PA concerning a 2 year old female who on approx. 11/28/00, was vaccinated with Hep-A virus vaccine inactivated. On approx. 11/29/00, the pt's grandparents called the PA to report that the child was excessively blinking her eyes. One week later, the PA observed the child at the office visit for 15 minutes and noted no excessive blinking. On approx. 12/11/00, the grandfather called the doctor's office to report when the child excessively blinks her eyes she also stops breathing and stops chewing. The child was referred to a pediatric doctor by the PA. Upon internal review apnea was considered to be an "Other Medical Event". Additional information has been requested. The reporter also reported on the pt's uncle on WAES00120970.
HPV1, OJ given before, 2 min after inj - dizzy, nauseous and pale. Pt laid back, water, sucker and cool compress given. BP 87/56, HR 58. Monitored for 25 min. VS improved. Pt said he felt better after interventions.
unable to move his limb; warmth; The patient experienced injection site pain, unable to move his limb, fever, warmth after getting the PNEUMOVAX 23; fever; Indication: For Pneumonia; Information has been received from a 51 years old male consumer, referring to himself. The patient's pertinent historical conditions included bronchitis, pneumonia and chronic sinus infection. Concomitant medication included rosuvastatin. The patient was allergic to levofloxacin (LEVAQUIN).  On 19-OCT-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (one shot, strength, dose detail, lot# and expiration date were unknown) through left biceps for pneumonia (product use in unapproved indication).  On the same date after vaccination, the patient experienced injection site pain, unable to move his limb, fever and warmth. Blood work was performed without results provided. The outcome of the events was reported as not recovered. The causality assessment was not reported.
Sore throat, fatigue, headache, and cough the following day after booster. Symptoms cleared up after two days.
pt was red 1130Pm placed on abd on waterbed;pt was discovered by grandfather when pt had not awaken by 8AM; taken to hosp pronounced dead by MD;
10-10-08 Complained of chest pain, sharp, Midsternal after receiving vaccines ~ Approximately 10-15 min post vaccination was given Ibuprofen, 2 tabs. Pain seemed to lessen when recumbent. Status checks 2hrs later - patient. Felt better, still had slight pain.
Patient received moderna booster 0.25 and was unaware that moderna will now be given for only 1st and 2nd dose.
STORAGE IN REFRIGERATOR (2°C - 8°C ) UP TO 30 DAYS. (VACCINE USED AFTER 10/16/2021)
Pt recvd 3rd dose of vax on 30JUL92 & 3 hrs following vax devel stomach cramping & vomiting;
Swollen and painful lymph nodes under the arm and around collar bone on the same side as injection. Extreme arm pain at injection site.     Vertigo. Sleepiness
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product information was not provided. Reporter stated that no treatment was given to patients.  Reporter also stated that the vaccines were stored in freezer and they took out one to two vials and placed in fridge each day as needed.
This is a spontaneous report from a contactable Physician via Pfizer sales representative. A 75-year-old male patient of an unspecified ethnicity received PREVNAR 13, via an unspecified route of administration on an unspecified date at single dose for immunisation. Medical history included chronic obstructive pulmonary disease and asthma from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient had received 2-3 PNEUMOVAX 23 vaccinations before the age of 65. He received a booster of pneumococcal vaccine polysacch 23V after 70 and did not fully respond. The patient received pneumococcal 13-val conjugate vaccine (dipht crm197 protein) within 5 months of pneumococcal vaccine polysacch 23V. On unspecified date, the titers still came back low after pneumococcal 13-val conjugate vaccine (dipht crm197 protein). The outcome of the event was unknown. The physician revaccinated the patient with pneumococcal 13-val conjugate vaccine (dipht crm197 protein). Information on the batch number has been requested.
EXCRUCIATING PAIN LASTING 6 HOURS AFTER VACCINATION.  PAIN WENT FROM AREA OF VACCINATION ALL THE WAY TO HER HAND.  PATIENT SAID PAIN WAS MUCH  BETTER THEN NEXT DAY.
8 hours after COVID vaccination, pt states she began vomiting and dry heaving. Also reports diarrhea, chills, body aches, sweats, and terrible headache.
mom noticed pt lips quivering like was cold then quivering moved to hands&then legs;when mom talked to pt was starring off;breathing was weird,noisy,diff to breathe;called ask-a-nurse;to ER on the way would drift off;speech slow;t105
Chills, headache, night sweats 2 days post shot and enlarged lymph node 4 days post vaccine.
exhibited hives around 6PM recvd inject @ 1000AM pt slept post inject;
Information has been received from a registered nurse concerning 9 patients who received the RECOMBIVAX HB series on schedule in 2008 and had negative hepatitis B titers. The patients received vaccinations from lot #s 660951/0398X, 662114/0866X (thimerosal free) and 660951/0399X) (not corresponding doses specified). The nurse also stated that the RECOMBIVAX HB was properly stored while in her facility. At the time of the report the patients had not recovered. It was unspecified if the patients sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Approximately 10 minutes after receiving her vaccines, patient's vision went dark and she fainted. Was roused immediately and felt fine after having some orange soda. After speaking to mom, patient had not eaten since an early breakfast. Pt was able to stand without any lightheadedness after a couple of minutes of being told to sit and drink her soda. She said she was hungry and she and mom left to get food.
Small local rash on the left arm, the same arm that I received the vaccine in.  Rash appeared 9 days after I received the first dose of the vaccine. Hot to the touch, dark pink, a little itchy. The recommended treatment is taking an antihistamine.